Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Translational research associated with TiFFANY trial of TAS-120 in FGFR-altered solid tumors
jRCT1080224720Completed
- Sponsor
- National Cancer Center Hospital East
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of futibatinib in Non-hematologic malignancy, sponsored by National Cancer Center Hospital East. Started Jun 2019; status: completed.
02
Drugs
futibatinib
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT1080224720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224720.